The RoMEO study: a real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cutaneous melanoma - L. Mortier; N. Meyer; J.-J. Grob; M. Pouriel; D. de Carpentier; P. Saïag (EJC Skin Cancer)